Otofarma SpA (MIL:OTO) Debt-to-Asset : 0.28 (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.52
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA Debt-to-Asset?

Otofarma SpA MIL:OTO -3.08% 16 Debt-to-Asset is 0.28 as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Otofarma SpA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €1.57 Mil. Otofarma SpA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €1.31 Mil. Otofarma SpA's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was €10.18 Mil. Otofarma SpA's debt to asset for the quarter that ended in Dec. 2024 was 0.28.


Otofarma SpA  (MIL:OTO) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Otofarma SpA Debt-to-Asset Related Terms


Otofarma SpA Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Debt-to-Asset Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
Debt-to-Asset
0.25 0.28

Otofarma SpA Semi-Annual Data
Dec23 Dec24
Debt-to-Asset 0.25 0.28

MIL:OTO vs ABT, SYK, MDT: Debt-to-Asset Comparison

For the Medical Devices subindustry, Otofarma SpA's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Otofarma SpA Debt-to-Asset vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Otofarma SpA's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Otofarma SpA's Debt-to-Asset falls into.


MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Otofarma SpA's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Otofarma SpA's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.28 mean?
Otofarma SpA (MIL:OTO) has a Debt-to-Asset of 0.28 as of Dec. 2024. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Otofarma SpA and its competitors.
Is Otofarma SpA's Debt-to-Asset too high?
Otofarma SpA's current Debt-to-Asset is 0.28. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Debt-to-Asset compare to ABT and SYK?
Otofarma SpA's Debt-to-Asset of 0.28 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Medical Devices & Instruments company?
A good Debt-to-Asset depends on the Medical Devices & Instruments industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Otofarma SpA and its competitors. Otofarma SpA's current Debt-to-Asset is 0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Debt-to-Asset of 0.28. The current Debt-to-Asset is 0.28. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Debt-to-Asset is 0.28 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.52
Price